Login / Signup

Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data.

P StaubachM MetzN Chapman-RotheC SiederM BräutigamMarcus MaurerKarsten Weller
Published in: Allergy (2017)
Our findings support omalizumab treatment in patients with severe H1-antihistamine-refractory CSU with angioedema.
Keyphrases
  • angiotensin converting enzyme
  • electronic health record
  • early onset
  • combination therapy
  • data analysis
  • childhood cancer